SUMMARY
The research of Teng Moua, M.D., focuses on fibrotic interstitial lung disease. Fibrotic interstitial lung disease is a heterogeneous group of often progressive and debilitating conditions involving the supportive lung tissue and small airways. Dr. Moua's research includes exploring and understanding aspects of illness progression, the impact of condition burden, and current treatment approaches on patient-reported and patient-centered outcomes.
Focus areas
- Mechanisms of progression in lung fibrosis. Dr. Moua studies the baseline characteristics and environmental factors that lead to the clinical and radiological progression of lung fibrosis.
- Patient-reported outcome measures. Dr. Moua studies the mechanisms by which symptoms and comorbidities affect patient experience, outcomes and quality of life in response to both medical and nonmedical therapies.
- Telehealth and home rehabilitation. In conjunction with the Mindful Breathing Lab of Roberto P. Benzo, M.D., Dr. Moua studies the clinical impact of health coaching and home pulmonary rehabilitation on respiratory-related quality of life and physical activity.
Significance to patient care
Fibrotic interstitial lung disease has a big impact on people's quality of life. It can worsen over time and lead to permanent loss of lung function or death. Progress has been made to better understand the processes that cause fibrosis, classify the disease and provide early treatment. Despite this progress, much is still unknown about how to slow or undo lung fibrosis. It is also difficult to predict how the disease will develop or how a patient will respond to treatment.
Additionally, there is limited supportive care to improve quality of life and patient well-being. This kind of care is often provided at the end of life or after the disease burden has worsened, limiting its potential impact. Dr. Moua and his colleagues lead research and collaborate with other researchers to explore and understand factors that may predict how the disease progresses and responds to treatment. He also offers rehabilitative and health coaching protocols to improve physical activity and patient-reported well-being.
Professional highlights
- Chair, Clinical Competency Committee, Pulmonary and Critical Care Medicine, Pulmonary and Critical Care Medicine Fellowship, Mayo Clinic, 2020-present.
- Center director, Mayo Clinic in Rochester, Pulmonary Fibrosis Foundation, 2018-present.
- Member, Data Monitoring Safety Board, National Heart, Lung, and Blood Institute, National Institutes of Health, 2018-present.
- Director, Interstitial Lung Disease and Pulmonary Vasculitis Fellowship, Mayo Clinic, 2014-2022.
- Director, Interstitial Lung Disease Clinic, Mayo Clinic, 2014-2022.
- Laureate Award, Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Mayo Clinic, 2021.
- Teacher of the Year, Division of Pulmonary and Critical Care Medicine, Mayo Fellows Association, Mayo Clinic, 2021.
- Associate program director, Critical Care Fellowship, Mayo Clinic, 2012-2018.
- Teacher of the Year, Critical Care Fellowship, Mayo Clinic, 2016.